ABLi Therapeutics ("ABLi"), a biotechnology company developing therapeutics to address diseases that are associated with activation of Abelson Tyrosine Kinases (c-Abl kinases), announces it has ...

Audio Timeline Slider: Use the left or right arrow keys to decrease or increase the slider value. Developed in 2015 by researchers studying the effects of diet on brain function and cognitive decline, ...

In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...

According to Precedence Research, the global AI in medical imaging market size is calculated at USD 2.57 trillion in 2026 and ...

Researchers found that people with anxiety disorders consistently show lower choline levels in key brain regions that regulate thinking and emotions. This biochemical difference may help explain why ...